Alexander Seelenberger Farba

PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX.

Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.

EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA.

Athelera LLC provides financial advisory services. The private company is based in New York, NY. The CEO of the company is Rodrigo Bitar.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.